paraproteinemias

Showing 1 - 11 of 11

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Multiple Myeloma, Multiple Myeloma in Relapse, Tumors Trial (Belantamab Mafodotin-Blmf, Daratumumab, Pomalidomide)

Not yet recruiting
  • Multiple Myeloma
  • +8 more
  • Belantamab Mafodotin-Blmf
  • +3 more
  • (no location specified)
Oct 13, 2022

Multiple Myeloma, Tumors, Tumor, Plasma Cell Trial (Belantamab Mafodotin-Blmf, Lenalidomide, Dexamethasone)

Not yet recruiting
  • Multiple Myeloma
  • +7 more
  • Belantamab Mafodotin-Blmf
  • +3 more
  • (no location specified)
Oct 11, 2022

Multiple Myeloma, Tumor, Plasma Cell, Tumors by Histologic Type Trial in United States (CYNK-001)

Active, not recruiting
  • Multiple Myeloma
  • +19 more
  • CYNK-001
  • Denver, Colorado
  • +8 more
May 24, 2022

Multiple Myeloma, Renal Impairment, Tumors, Plasma Cell Trial in Greece (Isatuximab, Bortezomib, Cyclophosphamide)

Not yet recruiting
  • Multiple Myeloma
  • +7 more
  • Athens, Greece
  • +5 more
Mar 28, 2022

Multiple Myeloma, Renal Impairment, Tumors, Plasma Cell Trial in Greece (Isatuximab, Pomalidomide, Dexamethasone)

Not yet recruiting
  • Multiple Myeloma
  • +7 more
  • Athens, Greece
  • +5 more
Mar 17, 2022

Multiple Myeloma, Tumors, Tumors, Plasma Cell Trial (Belantamab Mafodotin-Blmf, Daratumumab, Lenalidomide)

Not yet recruiting
  • Multiple Myeloma
  • +7 more
  • Belantamab Mafodotin-Blmf
  • +3 more
  • (no location specified)
Mar 4, 2022

Multiple Myeloma, Tumors, Plasma Cells Trial (Lenalidomide)

Withdrawn
  • Multiple Myeloma
  • +6 more
  • (no location specified)
Apr 9, 2018

Comprehensive Frailty Assessment

Completed
  • Myeloma, Multiple
  • +2 more
    • Columbus, Ohio
      The Ohio State University Hospital East
    Feb 27, 2018

    Cardiac Amyloidosis by Cardiac Magnetic Resonance Imaging

    Withdrawn
    • Amyloidosis
    • +2 more
    • Amyloidosis
    • Cardiac Amyloidosis
    • Cincinnati, Ohio
      University of Cincinnati
    Oct 24, 2017

    Leukemia, Lymphoma, Paraproteinemias Trial in St. Louis (USCOM scan, Fluid Bolus)

    Completed
    • Leukemia
    • +4 more
    • USCOM scan
    • Fluid Bolus
    • St. Louis, Missouri
      Washington University School of Medicine
    Aug 30, 2013

    Demyelinating Diseases, Paraproteinemias Trial run by the NINDS (intravenous immunoglobulin (IVIg))

    Completed
    • Demyelinating Diseases
    • Paraproteinemias
    • intravenous immunoglobulin (IVIg)
    • Bethesda, Maryland
      National Institute of Neurological Disorders and Stroke (NINDS)
    Mar 3, 2008